Identification of differentially expressed genes in clear cell renal cell carcinoma by analysis of full-length enriched cDNA library

Journal of Biomedical Science

Volumn 13, Issue 2, 2006, Pages 233-240

  Tang, Sai Wen ^a   Chang, Wen Hsin ^a   Chao, Yu Wei ^a   Lin, Chung Yei ^a   Chen, Hsiao Fen ^a   Lai, Yen Han ^a   Zhan, Bo Wen ^a   Su, Yih Ching ^a   Jane, Sen Wen ^a   Chen, Yu Chi ^a   Hsu, Chyong Ing ^a   Lin, Wei Chou ^b   Wang, Kao Chung ^b   Lai, Ming Kuen ^b   Lin, Jung Yaw ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Annexin A2; Argininosuccinate synthetase; Clear cell renal cell carcinoma; Full length cDNA library

Indexed keywords

ARGININOSUCCINATE SYNTHASE; LIPOCORTIN 2;

ARTICLE; CELL DIFFERENTIATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DNA LIBRARY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MOLECULAR CLONING; MOLECULAR MECHANICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ANNEXIN A2; ARGININOSUCCINATE SYNTHASE; CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; HUMANS; NEOPLASM PROTEINS;

EID: 33645345950     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9059-1     Document Type: Article

References (39)

1. Pantuck A.J., Zisman A. and Belldegrun A.S., The changing natural history of renal cell carcinoma. J. Urol. 166(5): 1611-1623, 2001.
2. Pavlovich C.P. and Schmidt L.S., Searching for the hereditary causes of renal-cell carcinoma. Nat. Rev. Cancer 4(5): 381-393, 2004.
3. Atkins D., Lichtenfels R. and Seliger B., Heat shock proteins in renal cell carcinomas. Contrib. Nephrol. 148: 35-56, 2005.
4. Cheville J.C., Lohse C.M., Zincke H., Weaver A.L. and Blute M.L., Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 27(5): 612-624, 2003.
5. Amato R.J., Chemotherapy for renal cell carcinoma. Semin. Oncol. 27(2): 177-186, 2000.
6. Russo P., Renal cell carcinoma: presentation, staging, and surgical treatment. Semin. Oncol. 27(2): 160-176, 2000.
7. Suzuki Y. and Sugano S., Construction of a full-length enriched and a 5′-end enriched cDNA library using the oligo-capping method. Methods Mol. Biol. 221: 73-91, 2003.
8. Suzuki Y., Yoshitomo-Nakagawa K., Maruyama K., Suyama A. and Sugano S., Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library. Gene 200(1-2): 149-156, 1997.
9. Livak K.J. and Schmittgen T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408, 2001.
10. Tanami H., Tsuda H., Okabe S., Iwai T., Sugihara K., Imoto I. and Inazawa J., Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis. Lab. Invest. 85(9): 1118-1129, 2005.
11. Snijders A.M., Schmidt B.L., Fridlyand J., Dekker N., Pinkel D., Jordan R.C. and Albertson D.G., Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24(26): 4232-4242, 2005.
12. Furuya M., Nishiyama M., Kimura S., Suyama T., Naya Y., Ito H., Nikaido T. and Ishikura H., Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. J. Pathol. 203(1): 551-558, 2004.
13. Kawasaki M., Maeda T., Hanasawa K., Ohkubo I. and Tani T., Effect of His-Gly-Lys motif derived from domain 5 of high molecular weight kininogen on suppression of cancer metastasis both in vitro and in vivo. J. Biol. Chem. 278(49): 49301-49307, 2003.
14. Visapaa H., Bui M., Huang Y., Seligson D., Tsai H., Pantuck A., Figlin R., Rao J.Y., Belldegrun A., Horvath S. and Palotie A., Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61(4): 845-850, 2003.
15. Amatschek S., Koenig U., Auer H., Steinlein P., Pacher M., Gruenfelder A., Dekan G., Vogl S., Kubista E., Heider K.H., Stratowa C., Schreiber M. and Sommergruber W., Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes. Cancer Res. 64(3): 844-856, 2004.
16. Planaguma J., Diaz-Fuertes M., Gil-Moreno A., Abal M., Monge M., Garcia A., Baro T., Thomson T.M., Xercavins J., Alameda F. and Reventos J., A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res. 64(24): 8846-8853, 2004.
17. Baba I., Shirasawa S., Iwamoto R., Okumura K., Tsunoda T., Nishioka M., Fukuyama K., Yamamoto K., Mekada E. and Sasazuki T., Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res. 60(24): 6886-6889, 2000.
18. Jiang Y., Harlocker S.L., Molesh D.A., Dillon D.C., Stolk J.A., Houghton R.L., Repasky E.A., Badaro R., Reed S.G. and Xu J., Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 21(14): 2270-2282, 2002.
19. Klee C.B., Ca2+-dependent phospholipid- (and membrane-) binding proteins. Biochemistry 27(18): 6645-6653, 1988.
20. Kumble K.D., Hirota M., Pour P.M. and Vishwanatha J.K., Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Res. 52(1): 163-167, 1992.
21. Frohlich M., Motte P., Galvin K., Takahashi H., Wands J. and Ozturk M., Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol. Cell. Biol. 10(6): 3216-3223, 1990.
22. Cole S.P., Pinkoski M.J., Bhardwaj G. and Deeley R.G., Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br. J. Cancer 65(4): 498-502, 1992.
23. Jindal H.K., Chaney W.G., Anderson C.W., Davis R.G. and Vishwanatha J.K., The protein-tyrosine kinase substrate, calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase alpha. J. Biol. Chem. 266(8): 5169-5176, 1991.
24. Kumble K.D., Iversen P.L. and Vishwanatha J.K., The role of primer recognition proteins in DNA replication: inhibition of cellular proliferation by antisense oligodeoxyribonucleotides. J. Cell. Sci. 101(Pt 1): 35-41, 1992.
25. Chiang Y., Schneiderman M.H. and Vishwanatha J.K., Annexin II expression is regulated during mammalian cell cycle. Cancer Res. 53(24): 6017-6021, 1993.
26. Filipenko N.R., MacLeod T.J., Yoon C.S. and Waisman D.M., Annexin A2 is a novel RNA-binding protein. J. Biol. Chem. 279(10): 8723-8731, 2004.
27. Dillon B.J., Prieto V.G., Curley S.A., Ensor C.M., Holtsberg F.W., Bomalaski J.S. and Clark M.A., Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation. Cancer 100(4): 826-833, 2004.
28. Maxwell S.A. and Rivera A., Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas. J. Biol. Chem. 278(11): 9784-9789, 2003.
29. Rivera A. and Maxwell S.A., The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 280(32): 29346-29354, 2005.
30. Blaine S.A., Wick M., Dessev C. and Nemenoff R.A., Induction of cPLA2 in lung epithelial cells and non-small cell lung cancer is mediated by Sp1 and c-Jun. J. Biol. Chem 276(46): 742737-42743, 2001.
31. Dimberg J., Samuelsson A., Hugander A. and Soderkvist P., Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res. 18(5A): 3283-3287, 1998.
32. Whitesell L. and Lindquist S.L., HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5(10): 761-772, 2005.
33. Kimura E., Enns R.E., Alcaraz J.E., Arboleda J., Slamon D.J. and Howell S.B., Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60. J. Clin. Oncol. 11(5): 891-898, 1993.
34. Ciocca D.R., Clark G.M., Tandon A.K., Fuqua S.A., Welch W.J. and McGuire W.L., Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J. Natl. Cancer. Inst. 85(7): 570-574, 1993.
35. Kaur J. and Ralhan R., Differential expression of 70-kDa heat shock-protein in human oral tumorigenesis. Int. J. Cancer 63(6): 774-779, 1995.
36. Santarosa M., Favaro D., Quaia M. and Galligioni E., Expression of heat shock protein 72 in renal cell carcinoma: possible role and prognostic implications in cancer patients. Eur. J. Cancer 33(6): 873-877, 1997.
37. Motzer R.J., Bander N.H. and Nanus D.M., Renal-cell carcinoma. N. Engl. J. Med. 335(12): 865-875, 1996.
38. Yamazaki D., Kurisu S. and Takenawa T., Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96(7): 379-386, 2005.
39. Fujita H., Okada F., Hamada J., Hosokawa M., Moriuchi T., Koya R.C. and Kuzumaki N., Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int. J. Cancer 93(6): 773-780, 2001.